DEEPAKNTR Q1 FY27 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹2,592 Cr
verified against source
Revenue YoY
35%
reported change
EBITDA
₹554 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Deepak Nitrite delivered a exceptional Q1 FY27 with record performance across all key metrics, driven by strong demand in both Phenolix and Advanced Intermediates segments. Consolidated revenue of 2,592 crores grew 35% YoY while EBITDA of 554 crores surged 159% YoY with 21% margin (expanding 1,000bps from 11% last year). PAT of 345 crores grew 207% YoY. The Phenolix business achieved its highest-ever quarterly performance with 36% revenue growth and 254% EBIT growth, supported by stable plant operations and competitive raw material sourcing. The Advanced Intermediates segment delivered 33% revenue growth with improving margins from recently commissioned nitration and hydrogenation facilities. Management highlighted the strategic completion of the ammonia-to-nitration integration chain, transitioning from a nitration company that buys nitric acid to a nitrogen company that nitrates. Capex for the 11,500 crore polycarbonate project remains on track with 1,200 crores already spent and debt fully tied up at competitive rates. Near-term risks include raw material price volatility, geopolitical disruptions affecting export freight costs, and competitive intensity in specialty chemicals. Management expressed confidence in sustaining improved earnings trajectory through new product ramp-ups and better product mix.
Colored figures show movement against the previous available record.
Guidance to track
- The 11,500 crore integrated polycarbonate project from propylene to BPA to polycarbonate and compounding is expected to commission in H2 FY28-29, with BPA following polycarbonate by a couple of months.
- MIBK and MIBC will be commissioned in August itself along with acetophenone, with the multi-purpose agrochemical intermediate facility commissioned within Q2 FY27.
- Additional 80-100 crores investment planned to debottleneck phenol assets from 3.5 lakh to 4 lakh TPA, targeting near-term completion.
- Several products across fluorination, amination, nitration, and specialty chemistry progressing through customer qualifications and commercialization, expected to broaden specialty portfolio and improve margins over next few years.
Risks flagged
- Despite successful Q1 procurement amid volatility, propane availability and pricing remain susceptible to market conditions and geopolitical disruptions, with Q2-Q3 spread sustainability questioned by analysts.
- Rising freight rates, insurance costs, and container/vessel availability disruptions are impacting export realizations, requiring ongoing customer engagement to shift to FOB models and larger parcel sizes.
- New molecule launches in Advanced Intermediates face red ocean conditions as competitors use cross-subsidization from other platforms to maintain market share, pressuring near-term margin profiles.
- Alkylation and multi-purpose plant commissioning delayed by contractual manpower unavailability and nationwide natural gas shortage, pushing full commercial volumes to January 2026.
Key quotes
- We're no longer a nitration company that buys nitric acid. We're now a nitrogen company that nitrates. This commissioning along with the expansion of our nitration and reduction capacity has materially strengthened our footprint.
- Deep Phenolics does not really have a significant participation in the global phenol market because our focus remains predominantly India and the domestic customers. India offers us a unique advantage and we offer in turn our customers a unique advantage.
- This project continues to progress in line with our execution roadmap and we remain focused on disciplined implementation while building a fully integrated advanced material platform for India.
Research modules